...
首页> 外文期刊>American Journal of Pathology: Official Publication of the American Association of Pathologists >A rat model for choroidal neovascularization using subretinal lipid hydroperoxide injection.
【24h】

A rat model for choroidal neovascularization using subretinal lipid hydroperoxide injection.

机译:使用视网膜下脂质过氧化氢注射的脉络膜新生血管的大鼠模型。

获取原文
获取原文并翻译 | 示例

摘要

The purpose of this study was to develop and characterize a rat model of choroidal neovascularization (CNV) as occurs in age-related macular degeneration. The lipid hydroperoxide 13(S)-hydroperoxy-9Z,11E-octadecadienoic acid (HpODE) is found in submacular Bruch's membrane in aged humans and has been reported to generate neovascularization in a rabbit model. Three weeks after a single subretinal injection of 30 microg of HpODE, eyes of Sprague-Dawley rats were harvested. Follow-up fluorescein angiography was done on other animals until 5 weeks postinjection. Histological studies, immunohistochemical staining, and flatmount choroids for CNV measurements were performed. In addition, we used murine neuronal, bovine endothelial, and human ARPE19 cells for testing the in vitro effects of HpODE. CNV developed in 85.7% of HpODE-injected eyes. The neovascular areas were significantly greater in HpODE-injected eyes compared with those in control eyes (P = 0.023). The CNV had maximum dye leakage at 3 weeks, which subsided by the 5th week. Histologically, CNV extended from the choriocapillaris into the subretinal space. ED1-positive macrophages were recruited to the site. In vitro assays demonstrated that only 30 ng/ml HpODE induced cell proliferation and migration of endothelial cells. HpODE-induced CNV was highly reproducible, and its natural course seems to be ideal for evaluating therapeutic modalities. Because HpODE has been isolated from aged humans, the HpODE-induced rat model seems to be a relevant experimental model for CNV in age-related macular degeneration.
机译:本研究的目的是开发和表征年龄相关性黄斑变性中发生的脉络膜新生血管(CNV)大鼠模型。脂质氢过氧化物13(S)-氢过氧-9Z,11E-十八碳二烯酸(HpODE)在老年人的黄斑下布鲁氏膜中发现,据报道在兔模型中产生新血管生成。视网膜下单次注射30微克HpODE后三周,收集了Sprague-Dawley大鼠的眼睛。对其他动物进行后续的荧光素血管造影术,直到注射后5周。进行了组织学研究,免疫组织化学染色和用于CNV测量的扁平脉络膜。此外,我们使用鼠类神经元,牛内皮细胞和人ARPE19细胞测试HpODE的体外作用。在注射HpODE的眼睛中出现CNV的比例为85.7%。与对照组相比,注射HpODE的眼睛的新生血管面积明显更大(P = 0.023)。 CNV在第3周出现最大的染料渗漏,这在第5周消退。从组织学上讲,CNV从脉络膜毛细血管延伸到视网膜下间隙。 ED1阳性巨噬细胞被招募到该站点。体外试验表明,只有30 ng / ml HpODE会诱导细胞增殖和内皮细胞迁移。 HpODE诱导的CNV具有很高的重现性,其自然过程似乎是评估治疗方式的理想选择。由于HpODE已从老年人中分离出来,因此HpODE诱导的大鼠模型似乎是与年龄相关的黄斑变性中CNV的相关实验模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号